Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 8Vincristine 6Etoposide 5prednylidene 4deltacortene 4Specimen Handling 4Prednisone 4Methotrexate 4Doxorubicin 4pegaspargase 3merphos 3fludarabine phosphate 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Rituximab 3Magnetic Resonance Spectroscopy 3Dexamethasone 3Cytarabine 3Calcium Dobesilate 3venetoclax 2Whole-Body Irradiation 2Tacrolimus 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Leucovorin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2CT-P10 2Asparaginase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Medrol Veriderm × 30 days × Clear all
NCT00792948 2026-05-29

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
97 enrolled 7 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡